Cara Therapeutics reported $9.17M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 68.89M 5.41M
Acelrx Pharmaceuticals ACRX:US $ 364K 180K
Aerie Pharmaceuticals AERI:US $ 68.08M 4.46M
Cara Therapeutics CARA:US $ 9.17M 5.54M
Chugai Pharma 4519:JP Y 268897M 122401M
Depomed DEPO:US $ 49.23M 0.31M
Endo International Ordinary Shares ENDP:US $ 498.9M 13.24M
Halozyme Therapeutics HALO:US $ 189.37M 75.61M
Horizon Pharma HZNP:US $ 673.31M 11.2M
JAZZ PHA JAZZ:US $ 594.03M 21.64M
Neurocrine Biosciences NBIX:US $ 279M 15.5M
Pacira Pharmaceuticals PCRX:US $ 91.1M 1M
Redhill Biopharma RDHL:US $ 25.93M 5.74M
Revance Therapeutics RVNC:US $ 5.59M 1.12M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M
Teva Pharmaceutical Industries TEVA:US $ 4471M 218M
Vanda Pharmaceuticals VNDA:US $ 28.8M 1.69M